Evolent Health Price to Book Ratio 2014-2025 | EVH
Historical price to book ratio values for Evolent Health (EVH) over the last 10 years. The current price to book ratio for Evolent Health as of November 05, 2025 is 0.83.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Evolent Health Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-11-05 | 6.35 | 0.65 | |
| 2025-06-30 | 11.26 | $9.70 | 1.16 |
| 2025-03-31 | 9.47 | $9.74 | 0.97 |
| 2024-12-31 | 11.25 | $10.36 | 1.09 |
| 2024-09-30 | 28.28 | $10.66 | 2.65 |
| 2024-06-30 | 19.12 | $10.79 | 1.77 |
| 2024-03-31 | 32.79 | $10.72 | 3.06 |
| 2023-12-31 | 33.03 | $10.94 | 3.02 |
| 2023-09-30 | 27.23 | $11.23 | 2.42 |
| 2023-06-30 | 30.30 | $11.35 | 2.67 |
| 2023-03-31 | 32.45 | $11.64 | 2.79 |
| 2022-12-31 | 28.08 | $8.27 | 3.40 |
| 2022-09-30 | 35.93 | $8.59 | 4.18 |
| 2022-06-30 | 30.71 | $6.80 | 4.51 |
| 2022-03-31 | 32.30 | $6.79 | 4.76 |
| 2021-12-31 | 27.67 | $7.77 | 3.56 |
| 2021-09-30 | 31.00 | $7.07 | 4.38 |
| 2021-06-30 | 21.12 | $7.17 | 2.95 |
| 2021-03-31 | 20.20 | $7.24 | 2.79 |
| 2020-12-31 | 16.03 | $7.35 | 2.18 |
| 2020-09-30 | 12.41 | $7.77 | 1.60 |
| 2020-06-30 | 7.12 | $7.57 | 0.94 |
| 2020-03-31 | 5.43 | $9.91 | 0.55 |
| 2019-12-31 | 9.05 | $10.98 | 0.82 |
| 2019-09-30 | 7.19 | $13.30 | 0.54 |
| 2019-06-30 | 7.95 | $13.57 | 0.59 |
| 2019-03-31 | 12.58 | $13.92 | 0.90 |
| 2018-12-31 | 19.95 | $14.44 | 1.38 |
| 2018-09-30 | 28.40 | $13.25 | 2.14 |
| 2018-06-30 | 21.05 | $13.42 | 1.57 |
| 2018-03-31 | 14.25 | $13.55 | 1.05 |
| 2017-12-31 | 12.30 | $13.52 | 0.91 |
| 2017-09-30 | 17.80 | $13.66 | 1.30 |
| 2017-06-30 | 25.35 | $13.07 | 1.94 |
| 2017-03-31 | 22.30 | $13.19 | 1.69 |
| 2016-12-31 | 14.80 | $13.43 | 1.10 |
| 2016-09-30 | 24.62 | $12.59 | 1.96 |
| 2016-06-30 | 19.20 | $12.76 | 1.50 |
| 2016-03-31 | 10.56 | $12.91 | 0.82 |
| 2015-12-31 | 12.11 | $15.84 | 0.76 |
| 2015-09-30 | 15.96 | $15.87 | 1.01 |
| 2015-06-30 | 19.50 | $16.08 | 1.21 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.746B | $2.555B |
| Evolent Health, Inc. is involved in the healthcare delivery and payment markets. The company provides technology-enabled services platform for providers to transition their organization in value-based payment models. Evolent Health, Inc. is based in Arlington, Virginia. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $48.395B | 59.05 |
| Tempus AI (TEM) | United States | $14.291B | 0.00 |
| Doximity (DOCS) | United States | $11.985B | 53.33 |
| Hims & Hers Health (HIMS) | United States | $9.884B | 76.72 |
| IRhythm Technologies (IRTC) | United States | $5.815B | 0.00 |
| Hinge Health (HNGE) | United States | $3.560B | 0.00 |
| Privia Health (PRVA) | United States | $3.071B | 227.46 |
| Heartflow (HTFL) | United States | $2.895B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.406B | 39.82 |
| Enovis (ENOV) | United States | $1.800B | 9.51 |
| 10x Genomics (TXG) | United States | $1.679B | 0.00 |
| Omnicell (OMCL) | United States | $1.642B | 32.79 |
| Clover Health Investments (CLOV) | United States | $1.520B | 0.00 |
| Schrodinger (SDGR) | United States | $1.455B | 0.00 |
| Azenta (AZTA) | United States | $1.400B | 61.08 |
| Phreesia (PHR) | United States | $1.358B | 0.00 |
| Claritev (CTEV) | United States | $1.071B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.697B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.632B | 0.00 |
| Talkspace (TALK) | United States | $0.576B | 114.67 |
| Veradigm (MDRX) | United States | $0.520B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.505B | 0.00 |
| Standard BioTools (LAB) | United States | $0.438B | 0.00 |
| Carlsmed (CARL) | United States | $0.322B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.305B | 0.00 |
| TruBridge (TBRG) | United States | $0.290B | 50.76 |
| CapsoVision (CV) | United States | $0.226B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.223B | 0.00 |
| Outset Medical (OM) | United States | $0.223B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.215B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.191B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.186B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.170B | 0.00 |
| CareCloud (CCLD) | United States | $0.125B | 5.67 |
| EUDA Health Holdings (EUDA) | Singapore | $0.119B | 0.00 |
| American Well (AMWL) | United States | $0.074B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.073B | 0.00 |
| Pulmonx (LUNG) | United States | $0.069B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.060B | 0.00 |
| HeartBeam (BEAT) | United States | $0.057B | 0.00 |
| 111 (YI) | China | $0.038B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.036B | 0.00 |
| Precipio (PRPO) | United States | $0.033B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.027B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.027B | 0.00 |
| Zhongchao (ZCMD) | China | $0.018B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.016B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.011B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.001B | 0.00 |